Transformational
Disease-Modifying
Advances in the Treatment
of Keratoconus & Myopia
Disease-Modifying
Advances in the Treatment
of Keratoconus & Myopia
iVeena Delivery Systems, Inc. is a privately held, clinical stage ophthalmology company developing non-surgical, non-invasive, pharmacologic innovations. These novel disease modifying interventions address significant unmet needs in the treatment of corneal disease and myopic conditions.
Lead programs comprise of novel proprietary eye drops; IVMED-80 (granted ODD) for keratoconus, and IVMED-85 for myopia.